HIGHLIGHTS
- who: Despina Fotiou and colleagues from the Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece have published the paper: Approach to Contemporary Risk Assessment, Prevention and Management of Thrombotic Complications inMultiple Myeloma, in the Journal: Cancers 2022, 6216 of 30/06/2014
- what: __SECTION__ 5. Conclusions.
- how: The authors identified only four randomized clinical trials in the literature that compare antithrombotic agents for VTE prevention for patients with MM on IMiDs and further evidence comes from non-randomized observational trials.
SUMMARY
Appropriate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.